company

GlaxoSmithKline

as of 2026-07-01
Monitor thisAsk about this
at a glance
24 trials sponsored · 21 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

21 assets
OlanzapineRisperidoneDrugGSK1018921GSK1034702GSK1144814GSK239512GSK729327Glycine Transporter-1 inhibitorKetoconazoleLorazepamLovazaNicotine LozengesSB- 773812 120 mgSB- 773812 60 mgSB-773812SB773812Talnetant[123]I-CNS 1261lamotriginepet/spect scan

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Olanzapine
small molecule
drug
Risperidone
small molecule
drug
Drug
small molecule
drug
GSK1018921
small molecule
drug
GSK1034702
small molecule
drug
GSK1144814
small molecule
drug
GSK239512
small molecule
drug
GSK729327
small molecule
drug